Eli Lilly and Company

39,451 Total Employees
Year Founded: 1876

Similar Companies Hiring

Artificial Intelligence • Big Data • Healthtech • Machine Learning • Software • Database • Analytics
37 Offices
2407 Employees
Computer Vision • Healthtech • Information Technology • Logistics • Machine Learning • Software • Manufacturing
10 Offices
1800 Employees
Artificial Intelligence • Healthtech • Professional Services • Analytics • Consulting
36 Offices
13000 Employees

Eli Lilly and Company Leadership & Management

Updated on February 06, 2026

This page was generated by Built In using publicly available information and AI-based analysis of common questions about the company. It has not been reviewed or approved by the company.

How are the managers & leadership at Eli Lilly and Company?

Strengths in strategic clarity, volume‑led growth execution, and employee support are accompanied by execution risks from long manufacturing timelines and inconsistencies in frontline leadership behaviors. Together, these dynamics suggest a well‑communicated, well‑funded plan whose success hinges on capacity ramp reliability and more uniformly positive management practices across sites.
Positive Themes About Eli Lilly and Company
  • Strategic Vision & Planning: Leadership communicates a consistent, measurable plan to scale incretins, de‑bottleneck access via LillyDirect, and build U.S. capacity, with explicit 2026 targets and milestones. Feedback suggests priorities are clearly articulated across channels and tied to concrete checkpoints.
  • Strong Execution: Management has repeatedly raised guidance and links growth to volume from Mounjaro/Zepbound while funding multi‑year U.S. manufacturing expansion to secure supply. Concrete capacity updates and new site commitments indicate follow‑through on stated priorities.
  • Employee Empowerment & Support: Feedback suggests a supportive, team‑oriented culture that emphasizes development, wellness, and work‑life balance. Training programs, inclusive practices, and professional norms are described as enabling long‑term career growth.
Considerations About Eli Lilly and Company
  • Poor Execution: Long build cycles for new facilities require bridging supply via existing sites and partners, creating near‑term timeline and ramp risks. Execution speed on manufacturing milestones will determine how securely demand can be met.
  • Biased or Inconsistent Leadership: Feedback suggests uneven experiences across sites and functions, including reports of favoritism and variable promotion practices. Perceived inconsistency in day‑to‑day management can undermine alignment with company‑level strategy.
  • Toxic or Disempowering Culture: Some accounts describe pockets of disrespectful behavior and politics that hinder change. Instances of yelling or overbearing styles are cited as detractors from an otherwise positive environment.
NEW
What does AI tell candidates about your employer brand?
Get your free AI reputation report today.
See AI Report
AI Report
AI Report

The insights on this page are generated by submitting structured prompts to some of the most popular large language models (“LLMs”) and summarizing recurring themes from the responses. Because the insights are generated using AI, they may contain errors. The insights do not necessarily reflect internal data, employee interviews, or verified company information. They may be influenced by incomplete, outdated, or inaccurate data, and may vary across LLM providers. These insights are intended for informational purposes only and should not be interpreted as a factual or definitive assessment of a company's reputation. Built In makes no representations or warranties regarding the accuracy, completeness, or reliability of this information, and disclaims any liability for any actions taken based on this information. If you are a representative of this company, and would like this page to be removed, you may contact us via this form.
Is This Your Company? Claim Profile